Yuanzan C. Ye

Person

North Brunswick, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 8,829,036
- Issue date Sep 9, 2014
- Merck Sharp & Dohme Corp.
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 8,778,980
- Issue date Jul 15, 2014
- Merck Sharp & Dohme Corp.
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 8,691,833
- Issue date Apr 8, 2014
- Merck Sharp & Dohme Corp.
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 8,691,831
- Issue date Apr 8, 2014
- Merck Sharp & Dohme Corp.
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 8,242,112
- Issue date Aug 14, 2012
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 8,178,513
- Issue date May 15, 2012
- Schering Corporation
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 7,973,067
- Issue date Jul 5, 2011
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 7,763,609
- Issue date Jul 27, 2010
- Schering Corporation
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 7,700,603
- Issue date Apr 20, 2010
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 7,592,348
- Issue date Sep 22, 2009
- Schering Corporation
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective D1/D5 receptor antagonists for the treatment of obesity a...
- Patent number 7,504,391
- Issue date Mar 17, 2009
- Schering Corporation
- Duane A. Burnett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neuropeptide receptor modulators
- Patent number 7,459,450
- Issue date Dec 2, 2008
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Muscarinic antagonists
- Patent number 6,458,812
- Issue date Oct 1, 2002
- Schering Corporation
- Brian A. McKittrick
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20150105354
- Publication date Apr 16, 2015
- MERCK SHARP & DOHME CORP.
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20140057910
- Publication date Feb 27, 2014
- Schering Corporation
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20130018066
- Publication date Jan 17, 2013
- Schering Corporation & Pharmacopeia Drug Discovery Inc.
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20120276118
- Publication date Nov 1, 2012
- Pharmacopeia Inc.
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20120231017
- Publication date Sep 13, 2012
- Pharmacopeia Inc.
- ZHAONING ZHU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20120231018
- Publication date Sep 13, 2012
- Pharmacopeia Inc.
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20110218194
- Publication date Sep 8, 2011
- Schering Corporation & Pharmacopeia Drug Discovery Inc.
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20100292203
- Publication date Nov 18, 2010
- Schering Corporation
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20090306047
- Publication date Dec 10, 2009
- Schering Corporation
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20090258868
- Publication date Oct 15, 2009
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic aspartyl protease inhibitors
- Publication number 20080200445
- Publication date Aug 21, 2008
- Schering Corporation and Pharmacopeia Drug Discovery, Inc.
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heterocyclic aspartyl protease inhibitors
- Publication number 20070072852
- Publication date Mar 29, 2007
- Schering Corporation
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heterocyclic aspartyl protease inhibitors
- Publication number 20060111370
- Publication date May 25, 2006
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Neuropeptide receptor modulators
- Publication number 20060089351
- Publication date Apr 27, 2006
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective D1/D5 receptor antagonists for the treatment of obesity a...
- Publication number 20050075325
- Publication date Apr 7, 2005
- Schering Corporation
- Duane A. Burnett
- C07 - ORGANIC CHEMISTRY

Yuanzan C. Ye

Person

Patents Grantslast 30 patents

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Selective D1/D5 receptor antagonists for the treatment of obesity a...

Neuropeptide receptor modulators

Muscarinic antagonists

Patents Applicationslast 30 patents

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Neuropeptide receptor modulators

Selective D1/D5 receptor antagonists for the treatment of obesity a...